Cell
Volume 75, Issue 2, 22 October 1993, Pages 295-305
ArticleThe human CD46 molecule is a receptor for measles virus (Edmonston strain)
References (63)
- et al.
The predicted primary structure of measles virus hemagglutinin
Virology
(1986) Round cell variant of measles virus: neurovirulence and pathogenesis of acute encephalitis in newborn hamsters
Virology
(1986)- et al.
The use of alkaline phosphatase conjugated anti-immunoglobulin with immunoblots for determining the specificity of monoclonal antibodies to protein mixtures
Meth. Enzymol.
(1986) - et al.
Measles virus polypeptide synthesis in infected cells
Virology
(1978) - et al.
Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible expression vectors
FEBS Lett.
(1990) Characterization of octyl glucoside-solubilized cell membrane receptors for binding measles virus
Virology
(1989)- et al.
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
Cell
(1986) - et al.
The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain)
- et al.
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 and HA2 viral polypeptides
Virology
(1980) - et al.
Genetic variability of the glycoprotein genes of current wild-type measles isolates
Virology
(1992)
The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation
Virology
(1993)
Epstein—Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
Cell
(1987)
The complement system
Fatal measles infection in marmosets: pathogenesis and prophylaxis
Infect. Immun.
(1980)
The Leucocyte Antigen Facts Book
(1993)
Purification of measles virus with preservation of infectivity and antigenicity
J. Gen. Virol.
(1979)
Molecular biology of defective measles viruses persisting in the human central nervous system
Studies on measles virus. I. Susceptibility of monkeys to the virus of measles
J. Exp. Med.
(1921)
Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis
J. Gen. Virol.
(1991)
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantitation of MCP by radioassay
Clin. Exp. Immunol.
(1991)
Development of attenuated measles virus vaccines
Markers for Edmonston virus
Am. J. Dis. Child.
(1962)
Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345
Nature
(1993)
Measles Virus and Its Biology
(1978)
Measles: a potentially finite history
J. Hist. Med.
(1973)
Measles virus-substance P receptor interactions
J. Clin. Invest.
(1990)
Measles virus-substance P receptor interactions: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication
Cell. Mol. Neurobiol.
(1992)
Development and evaluation of the Moraten measles virus vaccine
J. Am. Med. Assoc.
(1968)
Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen
Am. J. Reprod. Immunol. Microbiol.
(1988)
Replication and persistence of measles virus in defined subpopulations of human leukocytes
J. Virol.
(1975)
Propagation of measles virus in cultures of chick embryo cells
Cited by (897)
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
2023, International ImmunopharmacologyPseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
2023, Genes and DiseasesHemagglutinin stability as a key determinant of influenza A virus transmission via air
2023, Current Opinion in VirologyBioreceptors and immobilization techniques for transducing communicable diseases
2023, Health and Environmental Applications of Biosensing Technologies: Clinical and Allied Health Science PerspectiveClinical advances in oncolytic virotherapy for pediatric brain tumors
2022, Pharmacology and TherapeuticsOncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment
2022, Pharmacology and Therapeutics
Copyright © 1993